To award task non-clinical safety assessment of CTI-1601 to support ataxia indication to battelle
Ended Awarded Last action
- Contract number
- HHSN27100001
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,288
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR172002 · Posted Apr 7, 2020
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Award Notice · Posted May 2, 2016
- Contract value 100% obligated
- $4,288.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,870,711 | |
| Original award | $2,874,999 |
About this award
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $4,288 delivery order to Battelle Memorial Institute under the Center's master IDIQ contract for CRO Support for in vitro and in vivo toxicology studies. Under the order, Battelle will perform non-clinical safety assessment of CTI-1601 to support an ataxia indication as requested by the Center. The work will be conducted in Columbus, Ohio over an 18-month period concluding in March 2019. Funding is provided by the Department of Health and Human Services, and the pricing structure is cost plus fixed fee. The order supports the Center's programs to assess potential drug candidates and advance translational science.
Quick answers
Who was awarded contract HHSN27100001?
HHSN27100001 was awarded to Battelle Memorial Institute by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2017.
How much is contract HHSN27100001 worth?
The government has obligated $4,288 on HHSN27100001.
Which agency awarded contract HHSN27100001?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN27100001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract HHSN27100001 an order under another contract?
Yes. HHSN27100001 is a delivery order under HHSN271201700015I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract HHSN27100001 competed?
The extent of competition for HHSN27100001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award